162 related articles for article (PubMed ID: 8314829)
1. Routine use of adjusted low-dose warfarin to prevent venous thromboembolism after total hip replacement.
Paiement GD; Wessinger SJ; Hughes R; Harris WH
J Bone Joint Surg Am; 1993 Jun; 75(6):893-8. PubMed ID: 8314829
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty.
Lieberman JR; Wollaeger J; Dorey F; Thomas BJ; Kilgus DJ; Grecula MJ; Finerman GA; Amstutz HC
J Bone Joint Surg Am; 1997 Mar; 79(3):319-25. PubMed ID: 9070518
[TBL] [Abstract][Full Text] [Related]
3. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
[TBL] [Abstract][Full Text] [Related]
4. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group.
J Bone Joint Surg Am; 1994 Aug; 76(8):1174-85. PubMed ID: 8056798
[TBL] [Abstract][Full Text] [Related]
5. Intermittent pneumatic compression prophylaxis for proximal deep venous thrombosis after total hip replacement.
Woolson ST
J Bone Joint Surg Am; 1996 Nov; 78(11):1735-40. PubMed ID: 8934490
[TBL] [Abstract][Full Text] [Related]
6. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
7. Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin.
Francis CW; Pellegrini VD; Totterman S; Boyd AD; Marder VJ; Liebert KM; Stulberg BN; Ayers DC; Rosenberg A; Kessler C; Johanson NA
J Bone Joint Surg Am; 1997 Sep; 79(9):1365-72. PubMed ID: 9314399
[TBL] [Abstract][Full Text] [Related]
8. Warfarin prophylaxis to prevent mortality from pulmonary embolism after total hip replacement.
Amstutz HC; Friscia DA; Dorey F; Carney BT
J Bone Joint Surg Am; 1989 Mar; 71(3):321-6. PubMed ID: 2784442
[TBL] [Abstract][Full Text] [Related]
9. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
[TBL] [Abstract][Full Text] [Related]
10. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of prophylaxis in total hip replacement.
Paiement GD; Wessinger SJ; Harris WH
Am J Surg; 1991 Apr; 161(4):519-24. PubMed ID: 1903606
[TBL] [Abstract][Full Text] [Related]
12. Prevention of fatal pulmonary embolism with warfarin after total hip replacement.
Suomalainen O; Mäkelä AE; Harju A; Jaroma H
Int Orthop; 1996; 20(2):75-9. PubMed ID: 8739697
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of prophylactic preoperative administration of low-dose warfarin in cemented total knee prostheses].
Laflamme GY; Laflamme GH; Paiement GD; Beaumont P
Ann Chir; 1994; 48(8):717-22. PubMed ID: 7872620
[TBL] [Abstract][Full Text] [Related]
14. Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin.
Woolson ST; Watt JM
J Bone Joint Surg Am; 1991 Apr; 73(4):507-12. PubMed ID: 2013589
[TBL] [Abstract][Full Text] [Related]
15. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
[TBL] [Abstract][Full Text] [Related]
16. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
Eriksson BI; Ekman S; Lindbratt S; Baur M; Bach D; Torholm C; Kälebo P; Close P
J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
[TBL] [Abstract][Full Text] [Related]
17. Elevated partial thromboplastin time as an indicator of hemorrhagic risk in postoperative patients on warfarin prophylaxis.
Bell DF; Harris WH; Kuter DJ; Wessinger SJ
J Arthroplasty; 1988; 3(2):181-4. PubMed ID: 3397749
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of low-dose heparin--warfarin anticoagulation prophylaxis after total hip replacement arthroplasty.
Goss TP; Stinchfield FE; Cosgriff SW
Clin Orthop Relat Res; 1979 Jun; (141):134-7. PubMed ID: 477094
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic anticoagulation in total hip replacement.
D'Ambrosia RD; Lipscomb PR; McClain EJ; Wissinger HA; McDowell JH
Surg Gynecol Obstet; 1975 Apr; 140(4):523-7. PubMed ID: 1079374
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolism following total hip-replacement arthroplasty. The efficicy of dextran-aspirin and dextran-warfarin in prophylaxis.
Salvati EA; Lachiewicz P
J Bone Joint Surg Am; 1976 Oct; 58(7):921-5. PubMed ID: 977621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
